Oxidatively Modified Proteins in the Serous Subtype of Ovarian Carcinoma

被引:8
|
作者
Mehrabi, Sharifeh [1 ]
Partridge, Edward E. [2 ]
Seffens, William [3 ]
Yao, Xuebiao [3 ]
Aikhionbare, Felix O. [1 ]
机构
[1] Morehouse Sch Med, Dept Med, Atlanta, GA 30310 USA
[2] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35249 USA
[3] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA
关键词
CHRONIC INFLAMMATION; EPITHELIAL-CELLS; CARBONYL CONTENT; FREE-RADICALS; CANCER RISK; STRESS; DNA; PROTEOLYSIS; RESPONSES; OVULATION;
D O I
10.1155/2014/585083
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Serous subtype of ovarian cancer is considered to originate from fallopian epithelium mucosa that has been exposed to physiological changes resulting from ovulation. Ovulation influences an increased in inflammation of epithelial ovarian cells as results of constant exposure of cells to ROS. The imbalance between ROS and antioxidant capacities, as well as a disruption of redox signaling, causes a wide range of damage to DNA, proteins, and lipids. This study applied spectrophotometric, dinitrophenylhydrazone ( DNPH) assay, two-dimensional gel electrophoresis, and Western blot analyses to assess the levels of oxidatively modified proteins in 100 primary serous epithelial ovarian carcinoma and normal/surrounding tissues. These samples were obtained from 56 Caucasian and 44 African-American patients within the age range of 61 +/- 10 years. Analyses showed that the levels of reactive protein carbonyl groups increased as stages progressed to malignancy. Additionally, the levels of protein carbonyls in serous ovarian carcinoma among African Americans are 40% (P < 0.05) higher relative to Caucasian at similar advanced stages. Results suggest that oxidative stress is involved in the modification of carbonyl protein groups, leading to increased aggressiveness of epithelial ovarian tumors and may contribute to the disease's invasiveness among African Americans.
引用
收藏
页数:7
相关论文
共 50 条
  • [11] CARBONYL ASSAYS FOR DETERMINATION OF OXIDATIVELY MODIFIED PROTEINS
    LEVINE, RL
    WILLIAMS, JA
    STADTMAN, ER
    SHACTER, E
    OXYGEN RADICALS IN BIOLOGICAL SYSTEMS, PT C, 1994, 233 : 346 - 357
  • [12] DETERMINATION OF CARBONYL CONTENT IN OXIDATIVELY MODIFIED PROTEINS
    LEVINE, RL
    GARLAND, D
    OLIVER, CN
    AMICI, A
    CLIMENT, I
    LENZ, AG
    AHN, BW
    SHALTIEL, S
    STADTMAN, ER
    METHODS IN ENZYMOLOGY, 1990, 186 : 464 - 478
  • [13] Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
    Maeda, Daichi
    Ota, Satoshi
    Takazawa, Yutaka
    Ohashi, Kenichi
    Mori, Masaya
    Imamura, Tetsuo
    Nakagawa, Shunsuke
    Yano, Tetsu
    Taketani, Yuji
    Fukayama, Masashi
    VIRCHOWS ARCHIV, 2010, 457 (05) : 597 - 608
  • [14] Mucosal carcinoma of the fallopian tube coexists with ovarian cancer of serous subtype only: a study of Japanese cases
    Daichi Maeda
    Satoshi Ota
    Yutaka Takazawa
    Kenichi Ohashi
    Masaya Mori
    Tetsuo Imamura
    Shunsuke Nakagawa
    Tetsu Yano
    Yuji Taketani
    Masashi Fukayama
    Virchows Archiv, 2010, 457 : 597 - 608
  • [15] DITYROSINE - A MARKER FOR OXIDATIVELY MODIFIED PROTEINS AND SELECTIVE PROTEOLYSIS
    GIULIVI, C
    DAVIES, KJA
    OXYGEN RADICALS IN BIOLOGICAL SYSTEMS, PT C, 1994, 233 : 363 - 371
  • [16] Oxidatively modified proteins of cerebrospinal fluid in Alzheimer disease
    Faviou, E
    Dionyssiou-Asteriou, A
    Nounopoulos, C
    Papadimitriou, D
    Papadimitriou, A
    Proceedings of the Meeting of the Society for Free Radical Research Europe, 2005, : 43 - 45
  • [17] A Comprehensive Review of Ovarian Serous Carcinoma
    Hatano, Yuichiro
    Hatano, Kayoko
    Tamada, Maho
    Morishige, Ken-ichirou
    Tomita, Hiroyuki
    Yanai, Hiroyuki
    Hara, Akira
    ADVANCES IN ANATOMIC PATHOLOGY, 2019, 26 (05) : 329 - 339
  • [18] Importance of oxidatively modified proteins in chronic renal failure
    Descamps-Latscha, B
    Witko-Sarsat, V
    KIDNEY INTERNATIONAL, 2001, 59 : S108 - S113
  • [19] NANOG EXPRESSION IN OVARIAN SEROUS CARCINOMA
    Smrkolj, S.
    Suster, N. Kenda
    Virant-Klun, I.
    Grazio, S. Frkovic
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 727 - 727
  • [20] Metastatic Ovarian Serous Carcinoma of the Breast
    Akturk, Guray
    Durak, Merih Guray
    Cakir, Yasemin
    Koyuncuoglu, Meral
    Sevinc, Ali Ibrahim
    Canda, Tulay
    BREAST JOURNAL, 2017, 23 (03): : 362 - 364